Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Immunome, Inc. (IMNM) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-57.46M |
|
-- |
|
-- |
|
$60.14M |
|
$-60.14M |
|
$2.68M |
|
$-57.46M |
|
$-57.46M |
|
$-57.46M |
|
$-57.46M |
|
$-57.46M |
|
$-57.46M |
|
$-60.14M |
|
$-60.22M |
|
87.96M |
|
87.96M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$279.92M |
|
$11.56M |
|
$19.45M |
|
$299.38M |
|
$31.45M |
|
-- |
|
$4.01M |
|
$35.46M |
|
$263.92M |
|
$263.92M |
|
$263.92M |
|
91.71M |
|
| Cash Flow Statement Financials | |
$-142.97M |
|
$64.80M |
|
$207.56M |
|
$143.45M |
|
$272.85M |
|
$129.40M |
|
$17.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.90 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-148.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.77% |
|
-21.77% |
|
-19.19% |
|
-21.77% |
|
$2.88 |
|
$-1.69 |
|
$-1.63 |
|